Currently engaged in clinical trials to resolve ADHD, Fasoracetam is a member of the first nootropic family, the racetams. Today this drug is researched in hopes to discover a reliable and safe solution for ADHD symptoms. This means that we need to wait for conclusive evidence about its action mechanism before we dedicate a decision to add it to our nootropic stacks, but there are high hopes for this drug to succeed.
As it is expected from racetams, Fasoracetam is no different, providing ample amounts of neuroprotection, as well as mood regulation and anxiety reduction benefits. This makes Rregardless of the fact that results are not publicly available and no conclusions can be made, Fasoracetam one of the most promising drugs with ongoing research today, which can result in an exceptionally effective mental performance drug in the near future.